Skip to main content

C81.0 vs C81.46

C81.0 (Nodular lymphocyte predominant Hodgkin lymphoma) compared with C81.46 (Lymphocyte-rich Hodgkin lymphoma, intrapelvic lymph nodes), from the official CMS tabular data. Do not report these codes together: the official tabular list marks them Excludes1.

Can these codes be reported together?

No — do not report together. C81.46 carries an Excludes1 note covering C81.0: “nodular lymphocyte predominant Hodgkin lymphoma (C81.0-)”

Sole exception: when the two conditions are documented as unrelated to each other (ICD-10-CM Official Guidelines, Section I.A.12.a).

Side by side

C81.0Nodular lymphocyte predominant Hodgkin lymphomaC81.46Lymphocyte-rich Hodgkin lymphoma, intrapelvic lymph nodes
Billing statusNon-billable header

Report instead: C81.00, C81.01, C81.02, C81.03, C81.04

Billable
ClassificationC00-D49 — Neoplasms (C00-D49)C00-D49 — Neoplasms (C00-D49)
DefinitionNodular lymphocyte predominant Hodgkin lymphoma is a non-billable ICD-10-CM category code (C81.0).Lymphocyte-rich Hodgkin lymphoma, intrapelvic lymph nodes is a billable ICD-10-CM diagnosis code (C81.46).

Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources